• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study.肥胖相关性肾病、高血压与慢性肾脏病:弗雷明汉心脏研究。
Hypertension. 2011 Nov;58(5):784-90. doi: 10.1161/HYPERTENSIONAHA.111.175315. Epub 2011 Sep 19.
2
Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study.非酒精性脂肪肝与血脂异常和糖代谢异常相关,与内脏脂肪无关:弗雷明汉心脏研究。
Hepatology. 2010 Jun;51(6):1979-87. doi: 10.1002/hep.23593.
3
Heritability and genome-wide association analysis of renal sinus fat accumulation in the Framingham Heart Study.弗雷明汉心脏研究中肾窦脂肪堆积的遗传力和全基因组关联分析。
BMC Med Genet. 2011 Nov 1;12:148. doi: 10.1186/1471-2350-12-148.
4
Intramuscular fat and associations with metabolic risk factors in the Framingham Heart Study.弗雷明汉心脏研究中的肌肉内脂肪与代谢危险因素的相关性。
Arterioscler Thromb Vasc Biol. 2013 Apr;33(4):863-70. doi: 10.1161/ATVBAHA.112.301009. Epub 2013 Jan 24.
5
Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.腹部内脏和皮下脂肪组织分区:弗雷明汉心脏研究中与代谢危险因素的关联
Circulation. 2007 Jul 3;116(1):39-48. doi: 10.1161/CIRCULATIONAHA.106.675355. Epub 2007 Jun 18.
6
Prevalence, distribution, and risk factor correlates of high pericardial and intrathoracic fat depots in the Framingham heart study.弗雷明汉心脏研究中心的心包和胸内脂肪沉积的患病率、分布及相关危险因素。
Circ Cardiovasc Imaging. 2010 Sep;3(5):559-66. doi: 10.1161/CIRCIMAGING.110.956706. Epub 2010 Jun 4.
7
Associations of renal sinus fat with metabolic parameters, abdominal visceral adipose tissue, metabolic syndrome, fructose intake, and blood pressure control in obese individuals with hypertension: a cross-sectional study.肾窦脂肪与肥胖高血压个体的代谢参数、腹部内脏脂肪组织、代谢综合征、果糖摄入量及血压控制的相关性:一项横断面研究
J Nutr Sci. 2024 Dec 16;13:e94. doi: 10.1017/jns.2024.84. eCollection 2024.
8
Association of Blood Pressure and Risk of Cardiovascular and Chronic Kidney Disease in Hong Kong Hypertensive Patients.香港高血压患者的血压与心血管和慢性肾脏疾病风险的关联。
Hypertension. 2019 Aug;74(2):331-340. doi: 10.1161/HYPERTENSIONAHA.119.13123. Epub 2019 Jun 24.
9
Regional Fat Distribution and Blood Pressure Level and Variability: The Dallas Heart Study.区域脂肪分布与血压水平及变异性:达拉斯心脏研究
Hypertension. 2016 Sep;68(3):576-83. doi: 10.1161/HYPERTENSIONAHA.116.07876. Epub 2016 Jul 18.
10
Asymptomatic Hyperuricemia Without Comorbidities Predicts Cardiometabolic Diseases: Five-Year Japanese Cohort Study.无合并症的无症状高尿酸血症可预测心血管代谢疾病:日本五年队列研究
Hypertension. 2017 Jun;69(6):1036-1044. doi: 10.1161/HYPERTENSIONAHA.116.08998. Epub 2017 Apr 10.

引用本文的文献

1
Renal Function in Patients after Metabolic and Bariatric Surgery.代谢和减重手术后患者的肾功能
Obes Surg. 2025 Aug 9. doi: 10.1007/s11695-025-08149-0.
2
Renal Fat Accumulation Assessed by MRI or CT and Its Association with Clinical and Metabolic Disorders: A Systematic Imaging Review.通过MRI或CT评估的肾脂肪堆积及其与临床和代谢紊乱的关联:一项系统性影像学综述
J Clin Med. 2025 Jun 17;14(12):4305. doi: 10.3390/jcm14124305.
3
Renal ectopic fat deposition and hemodynamics in type 2 diabetes mellitus assessment with magnetic resonance imaging.2型糖尿病患者肾脏异位脂肪沉积及血流动力学的磁共振成像评估
Insights Imaging. 2025 Apr 27;16(1):93. doi: 10.1186/s13244-025-01971-1.
4
Metabolic Dysfunction-Associated Steatotic Liver Disease: Pathogenetic Links to Cardiovascular Risk.代谢功能障碍相关脂肪性肝病:与心血管风险的发病机制联系
Biomolecules. 2025 Jan 22;15(2):163. doi: 10.3390/biom15020163.
5
Hyperplasia of Fat-Containing Cells With Mature Adipocyte Marker Is Associated With Pancreatic Fat Enlargement.具有成熟脂肪细胞标志物的含脂肪细胞增生与胰腺脂肪增大有关。
Pancreas. 2025 Mar 1;54(3):e221-e226. doi: 10.1097/MPA.0000000000002422. Epub 2024 Nov 18.
6
Metabolic Syndrome, Kidney-Related Adiposity, and Kidney Microcirculation: Unraveling the Damage.代谢综合征、肾脏相关肥胖与肾脏微循环:揭示损伤机制
Biomedicines. 2024 Nov 27;12(12):2706. doi: 10.3390/biomedicines12122706.
7
Associations of renal sinus fat with metabolic parameters, abdominal visceral adipose tissue, metabolic syndrome, fructose intake, and blood pressure control in obese individuals with hypertension: a cross-sectional study.肾窦脂肪与肥胖高血压个体的代谢参数、腹部内脏脂肪组织、代谢综合征、果糖摄入量及血压控制的相关性:一项横断面研究
J Nutr Sci. 2024 Dec 16;13:e94. doi: 10.1017/jns.2024.84. eCollection 2024.
8
Sex Differences in Cardiovascular-Kidney-Metabolic Syndrome: 30-Year US Trends and Mortality Risks-Brief Report.心血管-肾脏-代谢综合征中的性别差异:美国30年趋势及死亡风险——简要报告
Arterioscler Thromb Vasc Biol. 2025 Jan;45(1):157-161. doi: 10.1161/ATVBAHA.124.321629. Epub 2024 Dec 12.
9
Perirenal Adipose Tissue: Clinical Implication and Therapeutic Interventions.肾周脂肪组织:临床意义与治疗干预
Indian J Nephrol. 2024 Nov-Dec;34(6):573-582. doi: 10.25259/ijn_532_23. Epub 2024 Aug 22.
10
Classifying Chronic Kidney Disease Stages Based on Predicted Value of Estimated Glomerular Filtration Rate From Serum Creatinine Levels Using Chronic Kidney Disease Risk Factors and Renal Sinus Anteroposterior Diameter on a Computed Tomography Image.基于血清肌酐水平预测的估计肾小球滤过率值、利用慢性肾脏病风险因素及计算机断层扫描图像上的肾窦前后径对慢性肾脏病进行分期
Cureus. 2024 Nov 5;16(11):e73085. doi: 10.7759/cureus.73085. eCollection 2024 Nov.

本文引用的文献

1
Renal sinus fat and poor blood pressure control in middle-aged and elderly individuals at risk for cardiovascular events.中年和老年心血管事件高危人群的肾窦脂肪与血压控制不佳。
Hypertension. 2010 Nov;56(5):901-6. doi: 10.1161/HYPERTENSIONAHA.110.157370. Epub 2010 Sep 13.
2
Neck circumference as a novel measure of cardiometabolic risk: the Framingham Heart study.颈围作为一种新的心血管代谢风险衡量指标:弗雷明汉心脏研究。
J Clin Endocrinol Metab. 2010 Aug;95(8):3701-10. doi: 10.1210/jc.2009-1779. Epub 2010 May 19.
3
Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study.非酒精性脂肪肝与血脂异常和糖代谢异常相关,与内脏脂肪无关:弗雷明汉心脏研究。
Hepatology. 2010 Jun;51(6):1979-87. doi: 10.1002/hep.23593.
4
Prevalence and trends in obesity among US adults, 1999-2008.美国成年人肥胖率的流行趋势及变化,1999-2008 年。
JAMA. 2010 Jan 20;303(3):235-41. doi: 10.1001/jama.2009.2014. Epub 2010 Jan 13.
5
Impact of obesity on renal structure and function in the presence and absence of hypertension: evidence from melanocortin-4 receptor-deficient mice.肥胖对存在和不存在高血压时肾脏结构和功能的影响:来自促黑素皮质素4受体缺陷小鼠的证据。
Am J Physiol Regul Integr Comp Physiol. 2009 Sep;297(3):R803-12. doi: 10.1152/ajpregu.00187.2009. Epub 2009 Jul 15.
6
Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss.肥胖与心血管疾病:风险因素、矛盾之处及体重减轻的影响。
J Am Coll Cardiol. 2009 May 26;53(21):1925-32. doi: 10.1016/j.jacc.2008.12.068.
7
Genome-wide association study of blood pressure and hypertension.全基因组关联研究血压和高血压。
Nat Genet. 2009 Jun;41(6):677-87. doi: 10.1038/ng.384. Epub 2009 May 10.
8
Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches.肥胖与高血压:机制、心肾后果及治疗方法
Med Clin North Am. 2009 May;93(3):733-51. doi: 10.1016/j.mcna.2009.02.010.
9
Differential estimation of CKD using creatinine- versus cystatin C-based estimating equations by category of body mass index.根据体重指数类别,使用基于肌酐和胱抑素C的估算方程对慢性肾脏病进行差异估计。
Am J Kidney Dis. 2009 Jun;53(6):993-1001. doi: 10.1053/j.ajkd.2008.12.043. Epub 2009 Apr 25.
10
Novel measurements of periaortic adipose tissue in comparison to anthropometric measures of obesity, and abdominal adipose tissue.与肥胖的人体测量指标以及腹部脂肪组织相比,主动脉周围脂肪组织的新型测量方法。
Int J Obes (Lond). 2009 Feb;33(2):226-32. doi: 10.1038/ijo.2008.267. Epub 2009 Jan 13.

肥胖相关性肾病、高血压与慢性肾脏病:弗雷明汉心脏研究。

Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study.

机构信息

Framingham Heart Study, Framingham, MA, USA.

出版信息

Hypertension. 2011 Nov;58(5):784-90. doi: 10.1161/HYPERTENSIONAHA.111.175315. Epub 2011 Sep 19.

DOI:10.1161/HYPERTENSIONAHA.111.175315
PMID:21931075
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3204377/
Abstract

Ectopic fat depots may mediate local and systemic disease. Animal models of diet-induced obesity demonstrate increased fat accumulation in the renal sinus. The association of renal sinus fat with hypertension, chronic kidney disease, and other metabolic disorders has not been studied in a large, community-based sample. Participants from the Framingham Heart Study (n=2923; mean age: 54 years; 51% women) underwent quantification of renal sinus fat area using computed tomography. High renal sinus fat ("fatty kidney") was defined using sex-specific 90th percentiles in a healthy referent subsample. Multivariable linear and logistic regression was used to model metabolic risk factors as a function of fatty kidney and log-transformed renal sinus fat. Multivariable models were adjusted for age, sex, and outcome-specific covariates and then additionally adjusted for body mass index or abdominal visceral adipose tissue. The prevalence of fatty kidney was 30.1% (n=879). Individuals with fatty kidney had a higher odds ratio (OR) of hypertension (OR: 2.12; P<0.0001), which persisted after adjustment for body mass index (OR: 1.49; P<0.0001) or visceral adipose tissue (OR: 1.24; P=0.049). Fatty kidney was also associated with an increased OR for chronic kidney disease (OR: 2.30; P=0.005), even after additionally adjusting for body mass index (OR: 1.86; P=0.04) or visceral adipose tissue (OR: 1.86; P=0.05). We observed no association between fatty kidney and diabetes mellitus after adjusting for visceral adipose tissue. In conclusion, fatty kidney is a common condition that is associated with an increased risk of hypertension and chronic kidney disease. Renal sinus fat may play a role in blood pressure regulation and chronic kidney disease.

摘要

异位脂肪沉积可能介导局部和全身疾病。饮食诱导肥胖的动物模型显示肾窦中脂肪堆积增加。肾窦脂肪与高血压、慢性肾脏病和其他代谢紊乱的相关性尚未在大型社区样本中进行研究。弗雷明汉心脏研究(Framingham Heart Study)的参与者(n=2923;平均年龄:54 岁;51%为女性)接受了使用计算机断层扫描对肾窦脂肪面积的定量评估。在健康参照亚组中,使用性别特异性第 90 百分位数定义高肾窦脂肪(“脂肪肾”)。多变量线性和逻辑回归用于模拟代谢危险因素作为脂肪肾和对数转换肾窦脂肪的函数。多变量模型调整了年龄、性别和特定结局的协变量,然后进一步调整了体重指数或腹部内脏脂肪组织。脂肪肾的患病率为 30.1%(n=879)。有脂肪肾的个体发生高血压的比值比(OR)更高(OR:2.12;P<0.0001),即使在调整了体重指数(OR:1.49;P<0.0001)或内脏脂肪组织(OR:1.24;P=0.049)后也是如此。脂肪肾与慢性肾脏病的 OR 增加也相关(OR:2.30;P=0.005),即使在进一步调整体重指数(OR:1.86;P=0.04)或内脏脂肪组织(OR:1.86;P=0.05)后也是如此。在调整内脏脂肪组织后,我们观察到脂肪肾与糖尿病之间没有关联。总之,脂肪肾是一种常见的疾病,与高血压和慢性肾脏病的风险增加有关。肾窦脂肪可能在血压调节和慢性肾脏病中发挥作用。